Literature DB >> 3093968

Alternative to diagnosis-related groups for newborn intensive care.

C S Phibbs, R H Phibbs, J J Pomerance, R L Williams.   

Abstract

Clinical and billing data were collected on all admissions to six California newborn intensive care units during a 6-month period. Charges were adjusted to costs using Medicaid cost to charge ratios and for inflation, and patients were classified by the diagnosis-related group (DRG) system. Costs were from 97% to 708% more than the proposed DRG reimbursement levels. Regression analysis showed that DRGs explained 22% of the variation in costs. An alternative model using binary variables to control for birth weight, assisted ventilation, surgery, survival, multiple births, and mode of discharge explained 42% of the variation in costs. In contrast to other proposed DRG alternatives, this simple model does not require special training or subjective decision-making.

Entities:  

Mesh:

Year:  1986        PMID: 3093968

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  5 in total

1.  Predictions of the affordable care act's impact on neonatal practice.

Authors:  S I Shah; H L Brumberg
Journal:  J Perinatol       Date:  2016-08       Impact factor: 2.521

2.  Colfosceril palmitate. A pharmacoeconomic evaluation of a synthetic surfactant preparation (Exosurf Neonatal) in infants with respiratory distress syndrome.

Authors:  H M Bryson; R Whittington
Journal:  Pharmacoeconomics       Date:  1994-12       Impact factor: 4.981

3.  The cost of neonatal care: reviewing the evidence.

Authors:  M Mugford
Journal:  Soz Praventivmed       Date:  1995

4.  Prevention: the cost-effectiveness of the California Diabetes and Pregnancy Program.

Authors:  R M Scheffler; L B Feuchtbaum; C S Phibbs
Journal:  Am J Public Health       Date:  1992-02       Impact factor: 9.308

5.  Explaining resource consumption among non-normal neonates.

Authors:  R M Schwartz; T Michelman; J Pezzullo; C S Phibbs
Journal:  Health Care Financ Rev       Date:  1991
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.